Call Us: +44 (0) 1752 753723[email protected]

Stem Cells Used to Treat Secondary Progressive Patients with MS in Clinical Trial

A phase 2 clinical study from an international group of research centers compared head-to-head autologous hematopoietic stem cell transplantation (AHSCT) and mitoxantrone in treating patients with secondary progressive or relapsing-remitting multiple sclerosis. The findings showed that MRI-detected brain lesions were reduced by 79% in patients undergoing AHSCT compared to...